A detailed history of Css LLC transactions in Pfizer Inc stock. As of the latest transaction made, Css LLC holds 33,099 shares of PFE stock, worth $872,489. This represents 0.1% of its overall portfolio holdings.

Number of Shares
33,099
Previous 15,999 106.88%
Holding current value
$872,489
Previous $447,000 114.09%
% of portfolio
0.1%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $473,670 - $536,769
17,100 Added 106.88%
33,099 $957,000
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $101,040 - $118,400
-4,000 Reduced 20.0%
15,999 $447,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $233,010 - $267,570
-9,000 Reduced 31.04%
19,999 $554,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $365,820 - $475,159
-14,000 Reduced 32.56%
28,999 $834,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $320,900 - $375,100
10,000 Added 30.3%
42,999 $1.43 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $328,692 - $380,289
9,100 Added 38.08%
32,999 $1.21 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $315,120 - $410,240
8,000 Added 50.32%
23,899 $975,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $236,260 - $288,414
5,399 Added 51.42%
15,899 $696,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $69,795 - $82,755
-1,500 Reduced 12.5%
10,500 $551,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $91,500 - $113,380
2,000 Added 20.0%
12,000 $622,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $330,560 - $490,000
8,000 Added 400.0%
10,000 $590,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $1.92 Million - $2.47 Million
-48,918 Reduced 96.07%
2,000 $86,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $1.53 Million - $1.86 Million
50,918 New
50,918 $1.67 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.